RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

If the hold isn't lifted, then what? Will COR have enough funds to stay afloat? Will they do another PIPE? I'd like people's thoughts about the steady-state SP (say 2 months post-decision) in the event of a negative outcome.

Also, we're treating this decision as a binary event. What about a raising of dosage rather than a lifting? What is the currently approved dosage, and how much higher would it have to go for CX-717 to have therapeutic value in treating ADHD?

The recent rise in SP reflects a consensus that the hold is likely to be lifted, but I want to estimate the downside, leaving aside the likelihood of that happening.

Thanks